These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12895200)

  • 21. Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C.
    Borgia G; Reynaud L; Gentile I; Cerini R; Ciampi R; Dello Russo M; Piazza M
    J Interferon Cytokine Res; 2001 Jul; 21(7):469-70. PubMed ID: 11506739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is steroid therapy needed in the treatment of destructive thyrotoxicosis induced by alpha-interferon in chronic hepatitis C?
    Minelli R; Valli MA; Di Seclì C; Finardi L; Chiodera P; Bertoni R; Ferrari C; Barilli AL; Coiro V; Saccani Jotti G; Delsignore R
    Horm Res; 2005; 63(4):194-9. PubMed ID: 15860921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin.
    Sjogren MH; Sjogren R; Lyons MF; Ryan M; Santoro J; Smith C; Reddy KR; Bonkovsky H; Huntley B; Faris-Young S
    Dig Dis Sci; 2007 Jun; 52(6):1540-7. PubMed ID: 17406822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic sclerosis after interferon alphacon-1 therapy for hepatitis C.
    Tahara H; Kojima A; Hirokawa T; Oyama T; Naganuma A; Maruta S; Okada K; Ban S; Yoshida K; Takagi H; Mori M
    Intern Med; 2007; 46(8):473-6. PubMed ID: 17443037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune disorders during interferon therapy in a patient with chronic hepatitis C infection: how many of them can be observed in a single patient?
    Hrstic I; Huic D; Bilusic M; Vucelic B
    J Clin Gastroenterol; 2006 Apr; 40(4):367-8. PubMed ID: 16633111
    [No Abstract]   [Full Text] [Related]  

  • 26. Recombinant interferon-alpha therapy and meno-metrorrhagia.
    Uberti-Foppa C; Finazzi R; De Bona A
    Br J Obstet Gynaecol; 1998 Mar; 105(3):367-8. PubMed ID: 9533004
    [No Abstract]   [Full Text] [Related]  

  • 27. Vitiligo associated with alpha-interferon in a patient with chronic active hepatitis C.
    Nouri K; Busso M; Machler BC
    Cutis; 1997 Dec; 60(6):289-90. PubMed ID: 9426968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C].
    Lee YN; Jeong SW; Lim JH; Ryu YS; Jeon SR; Kim SK; Jang JY; Kim YS; Kim BS; Roh MO
    Korean J Hepatol; 2010 Jun; 16(2):187-91. PubMed ID: 20606504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial.
    Alaimo G; Di Marco V; Ferraro D; Di Stefano R; Porrovecchio S; D'Angelo F; Calvaruso V; Craxì A; Almasio PL
    World J Gastroenterol; 2006 Nov; 12(42):6861-4. PubMed ID: 17106937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C.
    Gressens B; Gohy P
    Acta Gastroenterol Belg; 2004; 67(3):301-2. PubMed ID: 15587340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune polyglandular syndrome type 2 induced by treatment with interferon alpha.
    Krysiak R; Boldys A; Okopien B
    Am J Med Sci; 2011 Jun; 341(6):504-7. PubMed ID: 21412133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angioedema after interferon therapy for chronic hepatitis C.
    Ohmoto K; Yamamoto S
    Am J Gastroenterol; 2001 Apr; 96(4):1311-2. PubMed ID: 11316204
    [No Abstract]   [Full Text] [Related]  

  • 33. Multisystemic sarcoidosis associated with a second therapy for chronic hepatitis C.
    Froidure A; Horsmans Y; Lefebvre C
    Acta Gastroenterol Belg; 2009; 72(2):249-51. PubMed ID: 19637783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus.
    Cholongitas E; Samonakis D; Patch D; Senzolo M; Burroughs AK; Quaglia A; Dhillon A
    Transplantation; 2006 Feb; 81(3):488-90. PubMed ID: 16477242
    [No Abstract]   [Full Text] [Related]  

  • 35. Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with Peg interferon alfa-2a and ribavirin.
    Ennaifer R; Cheikh M; Romdhane H; Hefaiedh R; Ben Nejma H; Bel Hadj N
    Tunis Med; 2014 Jan; 92(1):42-3. PubMed ID: 24879173
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of reversible diabetes mellitus after cessation of interferon-alpha therapy for chronic hepatitis C infection.
    Tasi TN; Hsieh CH
    N Z Med J; 2004 Dec; 117(1207):U1230. PubMed ID: 15608817
    [No Abstract]   [Full Text] [Related]  

  • 37. Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
    Hayashi M; Kataoka Y; Tachikawa K; Koguchi H; Tanaka H
    Diabetes Res Clin Pract; 2009 Nov; 86(2):e19-21. PubMed ID: 19744739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sudden onset of diabetic ketoacidosis during consensus interferon therapy for chronic viral hepatitis C.
    Nylen ES; Marathe IC; Khan IA; Azevedo R; Hirsch KR
    Am J Med Sci; 2008 Apr; 335(4):329-30. PubMed ID: 18414077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe polyneuropathy under interferon therapy.
    Străin M; Străin R; Haiduc I
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):99. PubMed ID: 16680241
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of human recombinant erythropoietin plus IFN-alpha in patients affected by chronic hepatitis C.
    Di Fazio I; Motta M; Musumeci S; Neri S; Pistone G; Malaguarnera M
    J Interferon Cytokine Res; 2004 Oct; 24(10):594-9. PubMed ID: 15626156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.